---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-285627"
form_type: "8-K"
ticker: "VOR"
cik: "0001817229"
company_name: "Vor Biopharma Inc."
filed_at: "2024-12-27T23:59:59+00:00"
generated_at: "2026-05-28T23:05:54.492325+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Vor Bio raises $55.6M in PIPE; extends cash runway to 2025 clinical data readouts

## Summary
- Private placement of 55.87M shares and warrants for 69.84M shares at combined $0.99425 price, gross proceeds ~$55.6M.
- New investor Reid Hoffman led; existing investor RA Capital participated; each gets one board seat and one observer seat.
- Updated Phase 1/2 VCAR33 ALLO data expected H1 2025; Phase 1/2a trem-cel+Mylotarg data H2 2025.
- Net proceeds to fund pipeline development and general corporate; warrant exercise could add $58.5M.
- Warrants exercisable at $0.838/share, expire 7 years from issuance; closing expected Dec 30, 2024.

## SEC filing metadata
- accession: 0001193125-24-285627
- form_type: 8-K
- ticker: VOR
- cik: 0001817229
- company_name: Vor Biopharma Inc.
- filed_at: 2024-12-27T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 1.01, 3.02, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1817229/000119312524285627/0001193125-24-285627-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1817229/000119312524285627/d865206d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-285627
- JSON: https://secwatch.observer/filing/0001193125-24-285627.json
- Plain text: https://secwatch.observer/filing/0001193125-24-285627.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.